Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

PT582 – Is the DEA Sabotaging Psychedelic Research? Inside the Push to Schedule DOI and DOC, with Hamilton Morris

57:32
 
Share
 

Manage episode 462324117 series 2476237
Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris.

After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DOC have been incredible tools for researchers studying serotonin receptors, showing promise for chronic pain, anxiety, depression, and more.

Originally recorded as a livestream in November, we felt this discussion deserved more attention, as Morris was present during the hearing and saw first-hand the damage that can come from the combination of immense overreach and outdated beliefs.

He talks about:

  • The bureaucratic mess behind so much of what the DEA doe
  • The safety profile and research capacity of DOI and DOC and complete lack of data showing recreational us
  • The DEA’s claim that advocates weren’t expert
  • The fight to protect the Sonoran Desert toad and more!

While we wait for the conclusion of the hearing, head to Hamilton’s Patreon to hear his daily breakdowns. For links, head to the show notes page.

  continue reading

717 episodes

Artwork
iconShare
 
Manage episode 462324117 series 2476237
Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris.

After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DOC have been incredible tools for researchers studying serotonin receptors, showing promise for chronic pain, anxiety, depression, and more.

Originally recorded as a livestream in November, we felt this discussion deserved more attention, as Morris was present during the hearing and saw first-hand the damage that can come from the combination of immense overreach and outdated beliefs.

He talks about:

  • The bureaucratic mess behind so much of what the DEA doe
  • The safety profile and research capacity of DOI and DOC and complete lack of data showing recreational us
  • The DEA’s claim that advocates weren’t expert
  • The fight to protect the Sonoran Desert toad and more!

While we wait for the conclusion of the hearing, head to Hamilton’s Patreon to hear his daily breakdowns. For links, head to the show notes page.

  continue reading

717 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play